Conclusion:
Although it is a confusing question which patients are at risk of
myocarditis after the COVID-19 vaccines, given the protective role of
these vaccines against COVID-19 mortality, it is certain that this
limited and curative side effect is not a cause for hessitation in
vaccination. And it would be beneficial for the cardiologists who
perform the primary follow-up of these patients to know that it is
possible with SE to support the diagnosis and follow these patients,
even if CMR is not accesible.